Search alternatives:
point decrease » point increase (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
g decrease » _ decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
5 g » 5 mg (Expand Search)
point decrease » point increase (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
g decrease » _ decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
5 g » 5 mg (Expand Search)
-
201
-
202
-
203
-
204
-
205
M1 protein with T37A mutation confers increased pathogenicity and replication of H9N2 virus in mice.
Published 2022Subjects: -
206
Raw data V-trial.
Published 2024“…Total area yields in the V-trial ranged from 295 to 571 g m<sup>-2</sup> from lowest to highest DVP. …”
-
207
-
208
-
209
-
210
-
211
-
212
-
213
Delphinidin alters VEGF-A splicing to increase VEGF-A<sub>165</sub>b and decrease total VEGF-A expression.
Published 2019“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A<sub>165</sub>b relative to total VEGF-A<sub>165</sub> (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A<sub>165</sub>b before stripping and reprobing with panVEGF-A). …”
-
214
-
215
-
216
-
217
-
218
-
219
-
220